|
🐜
|
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
21 auth.
K. Moore,
N. Colombo,
G. Scambia,
Byoung-Gie Kim,
A. Oaknin,
M. Friedlander,
A. Lisyanskaya,
A. Floquet,
A. Leary,
G. Sonke,
...
C. Gourley,
Susana Banerjee,
A. Oza,
A. González-Martín,
C. Aghajanian,
W. Bradley,
C. Mathews,
Joyce F. Liu,
E. Lowe,
R. Bloomfield,
P. DiSilvestro
|
10 |
2018 |
10
🐜
|
|
🐜
|
Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
26 auth.
P. Benedetti Panici,
S. Basile,
Francesco Maneschi,
Andrea Alberto Lissoni,
M. Signorelli,
G. Scambia,
R. Angioli,
S. Tateo,
G. Mangili,
D. Katsaros,
G. Garozzo,
E. Campagnutta,
N. Donadello,
S. Greggi,
M. Melpignano,
...
F. Raspagliesi,
N. Ragni,
G. Cormio,
R. Grassi,
M. Franchi,
D. Giannarelli,
R. Fossati,
V. Torri,
M. Amoroso,
C. Croce,
C. Mangioni
|
10 |
2009 |
10
🐜
|
|
🐜
|
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
34 auth.
R. L. Coleman,
A. Oza,
D. Lorusso,
C. Aghajanian,
A. Oaknin,
A. Dean,
N. Colombo,
J. Weberpals,
A. Clamp,
G. Scambia,
A. Leary,
Robert W Holloway,
M. A. Gancedo,
P. Fong,
J. Goh,
...
D. O’Malley,
D. Armstrong,
J. García-Donas,
E. Swisher,
A. Floquet,
G. Konecny,
I. McNeish,
C. Scott,
T. Cameron,
L. Maloney,
J. Isaacson,
S. Goble,
C. Grace,
T. Harding,
M. Raponi,
James X. Sun,
K. Lin,
H. Giordano,
J. Ledermann
|
10 |
2017 |
10
🐜
|
|
🐜
|
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
30 auth.
I. Ray-Coquard,
P. Pautier,
S. Pignata,
D. Pérol,
A. González-Martín,
R. Berger,
K. Fujiwara,
I. Vergote,
N. Colombo,
J. Mäenpää,
F. Selle,
J. Sehouli,
D. Lorusso,
E. G. Guerra Alía,
A. Reinthaller,
...
S. Nagao,
C. Lefeuvre-Plesse,
U. Canzler,
G. Scambia,
A. Lortholary,
F. Marmé,
P. Combe,
N. de Gregorio,
M. Rodrigues,
P. Buderath,
C. Dubot,
A. Burges,
B. You,
E. Pujade-Lauraine,
P. Harter
|
10 |
2019 |
10
🐜
|
|
🐜
|
Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis
11 auth.
D. di Mascio,
A. Khalil,
G. Saccone,
G. Rizzo,
D. Buca,
M. Liberati,
...
J. Vecchiet,
L. Nappi,
G. Scambia,
V. Berghella,
F. D'antonio
|
10 |
2020 |
10
🐜
|
|
🐜
|
Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas
15 auth.
A. Bellacosa,
D. de Feo,
A. Godwin,
D. Bell,
J. Cheng,
D. Altomare,
M. Wan,
L. Dubeau,
G. Scambia,
V. Masciullo,
...
G. Ferrandina,
P. Panici,
S. Mancuso,
G. Neri,
J. Testa
|
9 |
1995 |
9
🐜
|
|
🐜
|
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study.
16 auth.
G. Agnelli,
G. Gussoni,
C. Bianchini,
M. Verso,
M. Mandalà,
L. Cavanna,
S. Barni,
R. Labianca,
F. Buzzi,
G. Scambia,
...
R. Passalacqua,
S. Ricci,
G. Gasparini,
V. Lorusso,
E. Bonizzoni,
M. Tonato
|
9 |
2009 |
9
🐜
|
|
🐜
|
Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial.
23 auth.
P. Panici,
A. Maggioni,
N. Hacker,
F. Landoni,
S. Ackermann,
E. Campagnutta,
K. Tamussino,
R. Winter,
A. Pellegrino,
S. Greggi,
...
R. Angioli,
N. Manci,
G. Scambia,
T. Dell'anna,
R. Fossati,
I. Floriani,
R. Rossi,
R. Grassi,
G. Favalli,
F. Raspagliesi,
D. Giannarelli,
L. Martella,
C. Mangioni
|
8 |
2005 |
8
🐜
|
|
🐜
|
Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies.
20 auth.
T. Hogberg,
M. Signorelli,
C. D. de Oliveira,
R. Fossati,
A. Lissoni,
B. Sorbe,
H. Andersson,
S. Grénman,
C. Lundgren,
P. Rosenberg,
...
K. Boman,
B. Tholander,
G. Scambia,
N. Reed,
G. Cormio,
G. Tognon,
J. Clarke,
T. Sawicki,
P. Zola,
G. Kristensen
|
8 |
2010 |
8
🐜
|
|
🐜
|
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms
28 auth.
P. Harter,
J. Sehouli,
D. Lorusso,
A. Reuss,
I. Vergote,
C. Marth,
Jae-Weon Kim,
F. Raspagliesi,
B. Lampe,
G. Aletti,
W. Meier,
D. Cibula,
A. Mustea,
S. Mahner,
I. Runnebaum,
...
B. Schmalfeldt,
A. Burges,
R. Kimmig,
G. Scambia,
S. Greggi,
F. Hilpert,
A. Hasenburg,
P. Hillemanns,
G. Giorda,
Ingo von Leffern,
C. Schade-Brittinger,
U. Wagner,
A. du Bois
|
8 |
2019 |
8
🐜
|
|
🐬
|
Role of microRNAs in drug-resistant ovarian cancer cells.
A. Sorrentino,
Changfeng Liu,
Antonio Addario,
C. Peschle,
G. Scambia,
C. Ferlini
|
8 |
2008 |
8
🐬
|
|
🐜
|
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.
30 auth.
S. Pignata,
G. Scambia,
D. Katsaros,
C. Gallo,
E. Pujade-Lauraine,
S. De Placido,
A. Bologna,
B. Weber,
F. Raspagliesi,
P. Panici,
G. Cormio,
R. Sorio,
M. Cavazzini,
G. Ferrandina,
E. Breda,
...
V. Murgia,
C. Sacco,
S. Cinieri,
V. Salutari,
C. Ricci,
C. Pisano,
S. Greggi,
R. Lauria,
D. Lorusso,
C. Marchetti,
L. Selvaggi,
S. Signoriello,
M. Piccirillo,
M. Di Maio,
F. Perrone
|
8 |
2014 |
8
🐜
|
|
🐜
|
Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning.
9 auth.
R. Manfredi,
P. Mirk,
G. Maresca,
P. Margariti,
A. Testa,
G. Zannoni,
...
Deborah Giordano,
G. Scambia,
P. Marano
|
8 |
2004 |
8
🐜
|
